Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease.

MLA

Rukmangathen, Rajalakshmi, et al. “Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson’s Disease.” Current Drug Discovery Technologies, vol. 16, no. 4, 2019, pp. 417–25. EBSCOhost, https://doi.org/10.2174/1570163815666180418144019.

APA

Rukmangathen, R., Yallamalli, I. M., & Yalavarthi, P. R. (2019). Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson’s Disease. Current Drug Discovery Technologies, 16(4), 417–425. https://doi.org/10.2174/1570163815666180418144019

Chicago

Rukmangathen, Rajalakshmi, Indira Muzib Yallamalli, and Prasanna Raju Yalavarthi. 2019. “Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson’s Disease.” Current Drug Discovery Technologies 16 (4): 417–25. doi:10.2174/1570163815666180418144019.